A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was once a pharmacologist’s dream is now much closer to reality. With a combination of hydrogels and artificial DNA, nanoparticles can be released in sequence under conditions similar to those in the human body.
It is becoming much more common for patients to be treated with several different medications. It is often necessary for the patient to take them at fixed intervals – a limitation that makes everyday life difficult and increases the risk of doses being skipped or forgotten.
Oliver Lieleg, Professor of Biomechanics and a member of the Munich School of BioEngineering at TUM, and doctoral candidate Ceren Kimna have now developed a process that could serve as the basis for medications containing several active ingredients that would reliably release them in the body in a pre-defined sequence at specified times. “For example, an ointment applied to a surgical incision could release pain medication first, followed by an anti-inflammatory drug and then a drug to reduce swelling,” explains Oliver Lieleg.
One active ingredient after the other
“Ointments or creams releasing their active ingredients with a time delay are not new in themselves,” says Oliver Lieleg. With the drugs currently in use, however, there is no guarantee that two or more active ingredients will not be released into the organism simultaneously.
To test the principle behind their idea, Oliver Lieleg and Ceren Kimna used nanometer-sized silver, iron oxide and gold particles embedded in a special gel-like substance known as a hydrogel. They then used a spectroscopic method to track the exit of the particles from the gel. The particles selected by the researchers have similar motion characteristics within the gel to the particles used to transport real active ingredients, but are easier and cheaper to make.
The special ingredient controlling the nanoparticles is artificial DNA. In nature, DNA is above all the carrier of genetic information. However, researchers are increasingly exploiting another property: The ability of DNA fragments to be combined with great accuracy, both in terms of the types of bonds and their strength, for example to build machines on a nanometer scale.
The DNA cascade: compress and then release at the right instant
The silver particles were released first. In the initial state, the particles were bound together by DNA fragments designed by Lieleg and Kimna using special software. The resulting particle clusters are so large that they are unable to move in the hydrogel. However, when a saline solution is added, they separate from the DNA. They can now move in the gel and drift to the surface. “Because the saline solution has approximately the same salinity as the human body, we were able to simulate conditions where the active ingredients would not be released until the medication is applied,” explains Ceren Kimna.
The mesh-like DNA structure surrounding the iron oxide particles consists of two types of DNA: The first has one end attached to the iron oxide particles. The second type is attached to the loose ends of the first type. These structures are not affected by the saline solution. The iron oxide particles can only be released when the first clusters have dissolved. This event releases not only the silver nanoparticles, but also DNA, which eliminates the “connection DNA” of the second cluster without forming connections itself. As a result, the iron oxide particles can separate. This releases DNA fragments which in turn act as the key to the third DNA-nanoparticle combination.
“The consistency of ointments makes them the most obvious solution for a hydrogel-based approach. However, this principle also has the potential to be used in tablets that could release several effective ingredients in the body in a specific order,” explains Prof. Lieleg.
Learn more: One at a time
The Latest on: Drug delivery
via Google News
The Latest on: Drug delivery
- Development of precision drug delivery tool to treat traumatic brain injuryon October 7, 2020 at 5:42 am
An interdisciplinary team of researchers at the University of Southern California has developed a precision drug delivery tool to selectively treat areas of the brain damaged during a traumatic brain ...
- The topical drug delivery market is projected to reach USD 129.8 billion by 2025 from USD 95.2 billion in 2020, at a CAGR of 6.4%on October 7, 2020 at 4:50 am
The topical drug delivery market is projected to reach USD 129.8 billion by 2025 from USD 95.2 billion in 2020, at a CAGR of 6.4% during ...
- Global Transdermal Drug Delivery System Market (2020 to 2027) - COVID-19 Impact and Analysison October 6, 2020 at 12:15 pm
The "Transdermal Drug Delivery System Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; Application; End User; ...
- Mysterious molecular phenomenon could boost precision of targeted drug deliveryon October 6, 2020 at 6:39 am
A growing area of medicine looks at how cellular binding observed in nature—where molecules like viruses or proteins bind to specific receptors on a cell—can be mimicked to aid drug delivery.
- Worldwide Pharmaceutical Drug Delivery Industry to 2027 - by Route of Administration, Application, End-user, and Geography - ResearchAndMarkets.comon October 6, 2020 at 5:47 am
COVID-19 Impact and Global Analysis by Route of Administration; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.
- Millimetre-precision drug delivery to the brainon October 5, 2020 at 9:47 am
Researchers at ETH Zurich have developed a method for concentrating and releasing drugs in the brain with pinpoint accuracy. This could make it possible in the future to deliver psychiatric and cancer ...
- Millimetre-precision drug delivery to the brainon October 5, 2020 at 7:22 am
The new method is non-invasive, with precise drug delivery in the brain controlled from outside the head using ultrasound. Mehmet Fatih Yanik, Professor of Neurotechnology, and his team of scientists ...
- Implantable Drug Delivery Devices Market will hit USD 17.5 Billion by 2021on October 4, 2020 at 10:07 am
Zion Market Research has published a new report titled “Implantable Drug Delivery Devices Market (Drug Infusion Pumps, Drug Delivery Devices, Bio-Absorbable Stents, Coronary Drug Eluting Stents, ...
- Outlook on the Worldwide Liposome Drug Delivery Industry to 2027 - by Product and Application - ResearchAndMarkets.comon October 1, 2020 at 7:00 am
Impact and Global Analysis by Product; Application" report has been added to ResearchAndMarkets.com's offering.
- Implantable Drug Delivery Devices Market Anticipated to Reach USD 413.2 Million by 2025 with CAGR of 5.4% during Forecast Period 2020-2025on September 25, 2020 at 1:11 am
Selbyville, Delaware, The research report on 'Implantable Drug Delivery Devices market' scrutinizes the current industry scenario to predict market size, market share, and projects valuation for ...
via Bing News